UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 163 filers reported holding UNIQURE NV in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $17,025 | +21.6% | 751 | 0.0% | 0.01% | +14.3% |
| Q3 2022 | $14,000 | +7.7% | 751 | +5.8% | 0.01% | +16.7% |
| Q2 2022 | $13,000 | +30.0% | 710 | +30.0% | 0.01% | +50.0% |
| Q1 2022 | $10,000 | +100.0% | 546 | +109.2% | 0.00% | +100.0% |
| Q4 2021 | $5,000 | +400.0% | 261 | +1350.0% | 0.00% | – |
| Q3 2021 | $1,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |